{"id":"https://openalex.org/W336656337","doi":null,"title":"Systemic therapy emergencies.","display_name":"Systemic therapy emergencies.","publication_year":2000,"publication_date":"2000-06-01","ids":{"openalex":"https://openalex.org/W336656337","mag":"336656337","pmid":"https://pubmed.ncbi.nlm.nih.gov/10864222"},"language":"en","primary_location":{"id":"pmid:10864222","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10864222","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in oncology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029048001","display_name":"Joan Albanell","orcid":"https://orcid.org/0000-0003-1239-4580","observed_orcids":["https://orcid.org/0000-0003-1239-4580"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"J Albanell","raw_affiliation_strings":["Medical Oncology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004300577","display_name":"Jose M Baselga","orcid":"https://orcid.org/0000-0003-1361-4063","observed_orcids":["https://orcid.org/0000-0003-1361-4063"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Baselga","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.7183,"has_fulltext":false,"cited_by_count":70,"citation_normalized_percentile":{"value":0.94467141,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"27","issue":"3","first_page":"347","last_page":"61"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.9560999870300293,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.9560999870300293,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.027300000190734863,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.005400000140070915,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-extravasation","display_name":"drug extravasation","score":0.9869999885559082},{"id":"https://openalex.org/keywords/hypersensitivity","display_name":"hypersensitivity","score":0.9800000190734863},{"id":"https://openalex.org/keywords/chemotherapy-side-effects","display_name":"chemotherapy side effects","score":0.4650000035762787},{"id":"https://openalex.org/keywords/antidotes","display_name":"antidotes","score":0.6060000061988831},{"id":"https://openalex.org/keywords/hyaluronidase","display_name":"hyaluronidase","score":0.9309999942779541},{"id":"https://openalex.org/keywords/sodium-thiosulfate","display_name":"sodium thiosulfate","score":0.9919999837875366},{"id":"https://openalex.org/keywords/dimethyl-sulfoxide","display_name":"dimethyl sulfoxide","score":0.9779999852180481},{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.7630000114440918},{"id":"https://openalex.org/keywords/l-asparaginase","display_name":"L-asparaginase","score":0.9869999885559082},{"id":"https://openalex.org/keywords/premedication","display_name":"premedication","score":0.9700000286102295},{"id":"https://openalex.org/keywords/interferon","display_name":"interferon","score":0.7450000047683716},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9850000143051147},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9079999923706055},{"id":"https://openalex.org/keywords/anthracyclines","display_name":"anthracyclines","score":0.7329999804496765},{"id":"https://openalex.org/keywords/vinca-alkaloids","display_name":"vinca alkaloids","score":0.8190000057220459}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.938111424446106},{"id":"https://openalex.org/C2778300832","wikidata":"https://www.wikidata.org/wiki/Q1589604","display_name":"Premedication","level":2,"score":0.6180976629257202},{"id":"https://openalex.org/C2779540182","wikidata":"https://www.wikidata.org/wiki/Q1076345","display_name":"Extravasation","level":2,"score":0.599863588809967},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.5491105914115906},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5246503353118896},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5241339802742004},{"id":"https://openalex.org/C25938499","wikidata":"https://www.wikidata.org/wiki/Q7663812","display_name":"Systemic administration","level":3,"score":0.47113460302352905},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.42718249559402466},{"id":"https://openalex.org/C2776093070","wikidata":"https://www.wikidata.org/wiki/Q621636","display_name":"Route of administration","level":2,"score":0.4125273823738098},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2644154727458954},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.22096583247184753},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D004342","descriptor_name":"Drug Hypersensitivity","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D004342","descriptor_name":"Drug Hypersensitivity","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D004630","descriptor_name":"Emergencies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005119","descriptor_name":"Extravasation of Diagnostic and Therapeutic Materials","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D005119","descriptor_name":"Extravasation of Diagnostic and Therapeutic Materials","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:10864222","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10864222","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in oncology","raw_type":"Journal Article"},{"id":"mag:336656337","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10864222","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2134710149","https://openalex.org/W7099274422","https://openalex.org/W2331221126","https://openalex.org/W2045372313","https://openalex.org/W2063293300","https://openalex.org/W4244085255","https://openalex.org/W2016485156","https://openalex.org/W3009695035","https://openalex.org/W2383750326","https://openalex.org/W2016562836"],"abstract_inverted_index":{"Systemic":[0],"oncologic":[1],"therapies":[2],"can":[3,27],"cause":[4,28],"multiple":[5],"emergency":[6],"situations.":[7],"There":[8],"are,":[9],"however,":[10],"two":[11,208],"unique":[12],"emergencies":[13,174],"directly":[14],"related":[15],"to":[16,65,128,169,187],"chemotherapy":[17,107],"administration:":[18],"drug":[19,145],"extravasation":[20,41],"and":[21,60,85,91,93,98,117,120,189,207,212],"hypersensitivity":[22],"reactions":[23],"(HSRs).":[24],"Most":[25],"drugs":[26],"varying":[29],"degrees":[30],"of":[31,40,47,52,63,71,106,126,150,193,224],"local":[32,53,68],"tissue":[33],"injury":[34],"when":[35],"extravasated.":[36],"The":[37,220],"medical":[38],"management":[39],"is":[42,166],"based":[43],"on":[44],"proper":[45],"maintenance":[46],"the":[48,61,67,72,124,148,157,162,173],"intravenous":[49],"line,":[50],"application":[51],"cooling":[54],"or":[55,146],"warming":[56],"for":[57,113,200,217],"certain":[58],"extravasations,":[59],"use":[62,125,199],"antidotes":[64],"prevent":[66,129],"toxic":[69],"action":[70],"extravasated":[73],"drug.":[74],"Antidotes":[75],"that":[76],"appear":[77],"useful":[78],"include":[79],"hyaluronidase":[80],"(for":[81,89,96],"vinca":[82],"alkaloids,":[83],"epipodophyllotoxins,":[84],"paclitaxel),":[86],"sodium":[87],"thiosulfate":[88],"mechlorethamine":[90],"cisplatin),":[92],"dimethylsulfoxide":[94],"(DMSO)":[95],"anthracyclines":[97],"mitomycin":[99],"C).":[100],"HSRs,":[101],"another":[102],"potential":[103],"adverse":[104],"effect":[105],"administration,":[108],"are":[109,227],"a":[110,133],"major":[111],"concern":[112],"therapy":[114,137],"with":[115,118,172],"taxanes":[116],"L-asparaginase,":[119],"their":[121,182],"administration":[122,149],"requires":[123],"premedication":[127,151],"these":[130,225],"reactions.":[131],"Once":[132],"HSR":[134],"has":[135],"occurred,":[136],"may":[138],"be":[139],"continued":[140],"by":[141,147,176],"using":[142],"an":[143],"analog":[144],"as":[152],"prophylaxis,":[153],"in":[154,197],"particular":[155],"if":[156],"reaction":[158],"was":[159],"minor.":[160],"On":[161],"other":[163],"hand,":[164],"it":[165],"also":[167],"pertinent":[168],"become":[170],"acquainted":[171],"induced":[175],"biological":[177],"agents,":[178],"taking":[179],"into":[180],"consideration":[181],"increasing":[183],"usages.":[184],"In":[185],"addition":[186],"interferons":[188],"interleukin-2":[190],"(IL-2),":[191],"both":[192],"which":[194],"have":[195],"been":[196],"clinical":[198],"several":[201],"years,":[202],"cytokine-toxin":[203],"fusion":[204],"proteins":[205],"(DAB3891L-2)":[206],"monoclonal":[209],"antibodies":[210],"(rituximab":[211],"trastuzumab)":[213],"were":[214],"recently":[215],"approved":[216],"cancer":[218],"therapy.":[219],"distinct":[221],"toxicity":[222],"profiles":[223],"agents":[226],"reviewed.":[228]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}